<b>Conclusions:</b> Goreisan demonstrates kidney-protective and diuretic effects in nephrotic syndrome, potentially through reducing systemic oxidative stress, modulating RAAS activation, and altering AQP2 trafficking. The gene discussed is AQP2; the disease is nephrotic syndrome.